Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II placebo-controlled double-blind crossover study of KHK6188 in postherpetic neuralgia
jRCT2080221716Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of khk6188 in postherpetic neuralgia (PHN) (2 arms), sponsored by Kyowa Kirin.
02
Drugs
khk6188
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on jRCT2080221716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221716.